These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30137645)

  • 21. Quantitative Systems Toxicology Analysis of In Vitro Mechanistic Assays Reveals Importance of Bile Acid Accumulation and Mitochondrial Dysfunction in TAK-875-Induced Liver Injury.
    Longo DM; Woodhead JL; Walker P; Herédi-Szabó K; Mogyorósi K; Wolenski FS; Dragan YP; Mosedale M; Siler SQ; Watkins PB; Howell BA
    Toxicol Sci; 2019 Feb; 167(2):458-467. PubMed ID: 30289550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse.
    Zhang J; He K; Cai L; Chen YC; Yang Y; Shi Q; Woolf TF; Ge W; Guo L; Borlak J; Tong W
    Chem Biol Interact; 2016 Aug; 255():45-54. PubMed ID: 27000539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
    Aleo MD; Luo Y; Swiss R; Bonin PD; Potter DM; Will Y
    Hepatology; 2014 Sep; 60(3):1015-22. PubMed ID: 24799086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury.
    Qiu X; Zhang Y; Liu T; Shen H; Xiao Y; Bourner MJ; Pratt JR; Thompson DC; Marathe P; Humphreys WG; Lai Y
    Mol Pharm; 2016 Apr; 13(4):1206-16. PubMed ID: 26910619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
    Dawson S; Stahl S; Paul N; Barber J; Kenna JG
    Drug Metab Dispos; 2012 Jan; 40(1):130-8. PubMed ID: 21965623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
    Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
    Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward predicting drug-induced liver injury: parallel computational approaches to identify multidrug resistance protein 4 and bile salt export pump inhibitors.
    Welch MA; Köck K; Urban TJ; Brouwer KL; Swaan PW
    Drug Metab Dispos; 2015 May; 43(5):725-34. PubMed ID: 25735837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative systems toxicology (QST) reproduces species differences in PF-04895162 liver safety due to combined mitochondrial and bile acid toxicity.
    Generaux G; Lakhani VV; Yang Y; Nadanaciva S; Qiu L; Riccardi K; Di L; Howell BA; Siler SQ; Watkins PB; Barton HA; Aleo MD; Shoda LKM
    Pharmacol Res Perspect; 2019 Dec; 7(6):e00523. PubMed ID: 31624633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravital Multiphoton Microscopy with Fluorescent Bile Salts in Rats as an In Vivo Biomarker for Hepatobiliary Transport Inhibition.
    Ryan J; Morgan RE; Chen Y; Volak LP; Dunn RT; Dunn KW
    Drug Metab Dispos; 2018 May; 46(5):704-718. PubMed ID: 29467212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug Induced Liver Injury (DILI). Mechanisms and Medicinal Chemistry Avoidance/Mitigation Strategies.
    Norman BH
    J Med Chem; 2020 Oct; 63(20):11397-11419. PubMed ID: 32511920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid/rifampicin-induced hepatotoxicity.
    Guo YX; Xu XF; Zhang QZ; Li C; Deng Y; Jiang P; He LY; Peng WX
    Toxicol Mech Methods; 2015; 25(5):382-7. PubMed ID: 25886055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idiosyncratic drug-induced liver injury.
    Ulzurrun E; Stephens C; Crespo E; Ruiz-Cabello F; Ruiz-Nuñez J; Saenz-López P; Moreno-Herrera I; Robles-Díaz M; Hallal H; Moreno-Planas JM; Cabello MR; Lucena MI; Andrade RJ
    Liver Int; 2013 Oct; 33(9):1378-85. PubMed ID: 23701583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals.
    Aleo MD; Shah F; He K; Bonin PD; Rodrigues AD
    Chem Res Toxicol; 2017 May; 30(5):1219-1229. PubMed ID: 28437613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BSEP inhibition: in vitro screens to assess cholestatic potential of drugs.
    Kis E; Ioja E; Rajnai Z; Jani M; Méhn D; Herédi-Szabó K; Krajcsi P
    Toxicol In Vitro; 2012 Dec; 26(8):1294-9. PubMed ID: 22120137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure based classification for bile salt export pump (BSEP) inhibitors using comparative structural modeling of human BSEP.
    Jain S; Grandits M; Richter L; Ecker GF
    J Comput Aided Mol Des; 2017 Jun; 31(6):507-521. PubMed ID: 28527154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic-Induced Elevations of Plasma Bile Acids in Rats Independent of Bsep Inhibition.
    Li Y; Hafey MJ; Duong H; Evers R; Cheon K; Holder DJ; Galijatovic-Idrizbegovic A; Sistare FD; Glaab WE
    Toxicol Sci; 2017 May; 157(1):30-40. PubMed ID: 28108666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver.
    Stieger B; Fattinger K; Madon J; Kullak-Ublick GA; Meier PJ
    Gastroenterology; 2000 Feb; 118(2):422-30. PubMed ID: 10648470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes.
    Ogimura E; Sekine S; Horie T
    Biochem Biophys Res Commun; 2011 Dec; 416(3-4):313-7. PubMed ID: 22108051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From hazard to risk prioritization: a case study to predict drug-induced cholestasis using physiologically based kinetic modeling.
    de Bruijn VMP; Rietjens IMCM
    Arch Toxicol; 2024 Sep; 98(9):3077-3095. PubMed ID: 38755481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting Drug-Induced Liver Injury with Bayesian Machine Learning.
    Williams DP; Lazic SE; Foster AJ; Semenova E; Morgan P
    Chem Res Toxicol; 2020 Jan; 33(1):239-248. PubMed ID: 31535850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.